Cargando…
Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-κB signaling and integrin binding
Osteosarcoma (OS) is a lethal disease with few known targeted therapies. Here, we show that decreased ATRX expression is associated with more aggressive tumor cell phenotypes, including increased growth, migration, invasion, and metastasis. These phenotypic changes correspond with activation of NF-κ...
Autores principales: | Bartholf DeWitt, Suzanne, Hoskinson Plumlee, Sarah, Brighton, Hailey E., Sivaraj, Dharshan, Martz, E.J., Zand, Maryam, Kumar, Vardhman, Sheth, Maya U., Floyd, Warren, Spruance, Jacob V., Hawkey, Nathan, Varghese, Shyni, Ruan, Jianhua, Kirsch, David G., Somarelli, Jason A., Alman, Ben, Eward, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536280/ https://www.ncbi.nlm.nih.gov/pubmed/36073547 http://dx.doi.org/10.1172/jci.insight.151583 |
Ejemplares similares
-
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus
por: Floyd, Warren, et al.
Publicado: (2023) -
A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma
por: Somarelli, Jason A., et al.
Publicado: (2020) -
Characterization of bending balloon actuators
por: Ko, Ung Hyun, et al.
Publicado: (2022) -
Exome sequencing of hepatocellular carcinoma in lemurs identifies potential cancer drivers: A pilot study
por: Gunady, Ella F, et al.
Publicado: (2022) -
A Fluorescence-Guided Laser Ablation System for Removal of Residual Cancer in a Mouse Model of Soft Tissue Sarcoma
por: Lazarides, Alexander L., et al.
Publicado: (2016)